Lasers for non-melanoma skin cancers

Jessica A. Savas, Jennifer A. Ledon, Kaitlein França, Anna H. Chacon, Keyvan Nouri

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

According to the most recent incidence data, approximately 3.5 million cases of non-melanoma skin cancer (NMSC) are diagnosed each year, affecting 2.1 million people in the United States alone (Rogers et al., Arch Dermatol 146:283-287, 2010). Basal cell carcinoma (BCC), squamous cell carcinoma (SCC), and squamous cell carcinoma in situ (SCCIS) represent the overwhelming majority of NMSCs, with BCC and its subtypes being the most common malignancy affecting Caucasians (Rogers et al., Arch Dermatol 146:283-287, 2010). Traditional treatments of NMSCs include standard excision, Mohs micrographic surgery, curettage and electrodessication (C&E), cryotherapy, radiotherapy, and topical cytotoxic therapy (e.g. fluorouracil). Some patients, especially those with multiple lesions, may not be amenable to several destructive or surgical interventions due to multiple comorbidities or fear of disfigurement, while others may be unable to tolerate the inflammatory side effects of topical preparations. A less invasive modality with fewer adverse effects and comparable efficacy is needed in certain patient populations, and to this end, lasers have shown great promise in carefully selected patients. This chapter will address the indications, procedural techniques, pre-operative and postoperative considerations as well as the prevention and management of complications when using lasers for the treatment of skin cancer.

Original languageEnglish (US)
Title of host publicationHandbook of Lasers in Dermatology
PublisherSpringer London
Pages293-306
Number of pages14
ISBN (Electronic)9781447153221
ISBN (Print)9781447153214
DOIs
StatePublished - Jan 1 2014

Fingerprint

Skin Neoplasms
Lasers
Basal Cell Carcinoma
Squamous Cell Carcinoma
Mohs Surgery
Cryotherapy
Curettage
Carcinoma in Situ
Fluorouracil
Fear
Comorbidity
Radiotherapy
Therapeutics
Incidence
Population
Neoplasms

Keywords

  • Basal cell carcinoma
  • Dermatology
  • Laser
  • Non-melanoma skin cancer
  • Skin cancer
  • Squamous cell carcinoma
  • Treatment

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Savas, J. A., Ledon, J. A., França, K., Chacon, A. H., & Nouri, K. (2014). Lasers for non-melanoma skin cancers. In Handbook of Lasers in Dermatology (pp. 293-306). Springer London. https://doi.org/10.1007/978-1-4471-5322-1_19

Lasers for non-melanoma skin cancers. / Savas, Jessica A.; Ledon, Jennifer A.; França, Kaitlein; Chacon, Anna H.; Nouri, Keyvan.

Handbook of Lasers in Dermatology. Springer London, 2014. p. 293-306.

Research output: Chapter in Book/Report/Conference proceedingChapter

Savas, JA, Ledon, JA, França, K, Chacon, AH & Nouri, K 2014, Lasers for non-melanoma skin cancers. in Handbook of Lasers in Dermatology. Springer London, pp. 293-306. https://doi.org/10.1007/978-1-4471-5322-1_19
Savas JA, Ledon JA, França K, Chacon AH, Nouri K. Lasers for non-melanoma skin cancers. In Handbook of Lasers in Dermatology. Springer London. 2014. p. 293-306 https://doi.org/10.1007/978-1-4471-5322-1_19
Savas, Jessica A. ; Ledon, Jennifer A. ; França, Kaitlein ; Chacon, Anna H. ; Nouri, Keyvan. / Lasers for non-melanoma skin cancers. Handbook of Lasers in Dermatology. Springer London, 2014. pp. 293-306
@inbook{be4ebcd5c7004bef86e97580740259d8,
title = "Lasers for non-melanoma skin cancers",
abstract = "According to the most recent incidence data, approximately 3.5 million cases of non-melanoma skin cancer (NMSC) are diagnosed each year, affecting 2.1 million people in the United States alone (Rogers et al., Arch Dermatol 146:283-287, 2010). Basal cell carcinoma (BCC), squamous cell carcinoma (SCC), and squamous cell carcinoma in situ (SCCIS) represent the overwhelming majority of NMSCs, with BCC and its subtypes being the most common malignancy affecting Caucasians (Rogers et al., Arch Dermatol 146:283-287, 2010). Traditional treatments of NMSCs include standard excision, Mohs micrographic surgery, curettage and electrodessication (C&E), cryotherapy, radiotherapy, and topical cytotoxic therapy (e.g. fluorouracil). Some patients, especially those with multiple lesions, may not be amenable to several destructive or surgical interventions due to multiple comorbidities or fear of disfigurement, while others may be unable to tolerate the inflammatory side effects of topical preparations. A less invasive modality with fewer adverse effects and comparable efficacy is needed in certain patient populations, and to this end, lasers have shown great promise in carefully selected patients. This chapter will address the indications, procedural techniques, pre-operative and postoperative considerations as well as the prevention and management of complications when using lasers for the treatment of skin cancer.",
keywords = "Basal cell carcinoma, Dermatology, Laser, Non-melanoma skin cancer, Skin cancer, Squamous cell carcinoma, Treatment",
author = "Savas, {Jessica A.} and Ledon, {Jennifer A.} and Kaitlein Fran{\cc}a and Chacon, {Anna H.} and Keyvan Nouri",
year = "2014",
month = "1",
day = "1",
doi = "10.1007/978-1-4471-5322-1_19",
language = "English (US)",
isbn = "9781447153214",
pages = "293--306",
booktitle = "Handbook of Lasers in Dermatology",
publisher = "Springer London",

}

TY - CHAP

T1 - Lasers for non-melanoma skin cancers

AU - Savas, Jessica A.

AU - Ledon, Jennifer A.

AU - França, Kaitlein

AU - Chacon, Anna H.

AU - Nouri, Keyvan

PY - 2014/1/1

Y1 - 2014/1/1

N2 - According to the most recent incidence data, approximately 3.5 million cases of non-melanoma skin cancer (NMSC) are diagnosed each year, affecting 2.1 million people in the United States alone (Rogers et al., Arch Dermatol 146:283-287, 2010). Basal cell carcinoma (BCC), squamous cell carcinoma (SCC), and squamous cell carcinoma in situ (SCCIS) represent the overwhelming majority of NMSCs, with BCC and its subtypes being the most common malignancy affecting Caucasians (Rogers et al., Arch Dermatol 146:283-287, 2010). Traditional treatments of NMSCs include standard excision, Mohs micrographic surgery, curettage and electrodessication (C&E), cryotherapy, radiotherapy, and topical cytotoxic therapy (e.g. fluorouracil). Some patients, especially those with multiple lesions, may not be amenable to several destructive or surgical interventions due to multiple comorbidities or fear of disfigurement, while others may be unable to tolerate the inflammatory side effects of topical preparations. A less invasive modality with fewer adverse effects and comparable efficacy is needed in certain patient populations, and to this end, lasers have shown great promise in carefully selected patients. This chapter will address the indications, procedural techniques, pre-operative and postoperative considerations as well as the prevention and management of complications when using lasers for the treatment of skin cancer.

AB - According to the most recent incidence data, approximately 3.5 million cases of non-melanoma skin cancer (NMSC) are diagnosed each year, affecting 2.1 million people in the United States alone (Rogers et al., Arch Dermatol 146:283-287, 2010). Basal cell carcinoma (BCC), squamous cell carcinoma (SCC), and squamous cell carcinoma in situ (SCCIS) represent the overwhelming majority of NMSCs, with BCC and its subtypes being the most common malignancy affecting Caucasians (Rogers et al., Arch Dermatol 146:283-287, 2010). Traditional treatments of NMSCs include standard excision, Mohs micrographic surgery, curettage and electrodessication (C&E), cryotherapy, radiotherapy, and topical cytotoxic therapy (e.g. fluorouracil). Some patients, especially those with multiple lesions, may not be amenable to several destructive or surgical interventions due to multiple comorbidities or fear of disfigurement, while others may be unable to tolerate the inflammatory side effects of topical preparations. A less invasive modality with fewer adverse effects and comparable efficacy is needed in certain patient populations, and to this end, lasers have shown great promise in carefully selected patients. This chapter will address the indications, procedural techniques, pre-operative and postoperative considerations as well as the prevention and management of complications when using lasers for the treatment of skin cancer.

KW - Basal cell carcinoma

KW - Dermatology

KW - Laser

KW - Non-melanoma skin cancer

KW - Skin cancer

KW - Squamous cell carcinoma

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=85028390583&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028390583&partnerID=8YFLogxK

U2 - 10.1007/978-1-4471-5322-1_19

DO - 10.1007/978-1-4471-5322-1_19

M3 - Chapter

SN - 9781447153214

SP - 293

EP - 306

BT - Handbook of Lasers in Dermatology

PB - Springer London

ER -